{
    "URL": "https://doi.org/10.1371/journal.pntd.0000818",
    "Published": "September 7, 2010",
    "Subject_Areas": [
        "Cost-effectiveness analysis",
        "Drug therapy",
        "Indirect costs",
        "Kala-azar",
        "Leishmaniasis",
        "Drug prices",
        "Health care facilities",
        "India"
    ],
    "Authors": {
        "Filip Meheus": [
            "Department of Public Health, Institute of Tropical Medicine, Antwerp, Belgium"
        ],
        "Manica Balasegaram": [
            "Drugs for Neglected Diseases Initiative, Geneva, Switzerland"
        ],
        "Piero Olliaro": [
            "United Nations Children's Fund (UNICEF)/United Nations Development Programme (UNDP)/World Bank/World Health Organization (WHO) Special Programme for Research and Training in Tropical Diseases, World Health Organization, Geneva, Switzerland",
            "Nuffield Department of Medicine,The Centre for Tropical Medicine, Centre for Tropical Medicine and Vaccinology, University of Oxford, Churchill Hospital, Oxford, United Kingdom"
        ],
        "Shyam Sundar": [
            "Institute of Medical Sciences, Banaras Hindu University, Varanasi, India"
        ],
        "Suman Rijal": [
            "B.P. Koirala Institute of Medical Sciences, Dharan, Nepal"
        ],
        "Md. Abul Faiz": [
            "Sir Salimullah Medical College, Mitford, Dhaka, Bangladesh"
        ],
        "Marleen Boelaert": [
            "Department of Public Health, Institute of Tropical Medicine, Antwerp, Belgium"
        ]
    }
}